Acute bacterial meningitis in the newborn

Area of Science:

• Neonatalogy
• Infectious Diseases
• Pediatric Neurology

Background:

• Acute bacterial meningitis is a significant threat during the neonatal period, carrying high mortality and long-term sequelae.
• The incidence remains stable, despite changes in the neonatal population, with complex pathogenesis and a wide range of causative bacteria.
• Predisposing factors are limited, primarily maternal infection, with distinct bacterial profiles in early versus late-onset meningitis.

Purpose of the Study:

• To review the current understanding of neonatal meningitis, including incidence, pathogenesis, and clinical presentation.
• To outline recommended antibiotic therapies and discuss emerging treatment strategies.
• To highlight the challenges in diagnosis and the importance of prompt treatment.

Main Methods:

• Literature review of studies on neonatal meningitis.
• Analysis of incidence rates, causative pathogens, and mortality data.
• Summary of current treatment guidelines and future therapeutic directions.

Main Results:

• Mortality rates vary by pathogen: highest with Gram-negative bacilli (>30%), lower with Group B Streptococcus and other Gram-positives.
• Clinical presentation is non-specific, complicating early diagnosis.
• Recommended treatment involves third-generation cephalosporins, potentially with aminoglycosides or ampicillin based on risk factors.

Conclusions:

• Prompt initiation of appropriate antibiotic therapy is critical due to non-specific symptoms.
• Current treatment strategies focus on broad-spectrum antibiotics, with ongoing research into managing endotoxin release.
• Steroids are not recommended for neonatal meningitis, unlike in pediatric cases.